MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Will Medtech Rise to FDA's Sterilization Challenge?

TAGS: R&D News

Pixabay

Will Medtech Rise to FDA's Sterilization Challenge?

FDA issued two challenges Monday, both of which aim to address the environmental concerns surrounding the use of a gas called ethylene oxide to sterilize medical devices.

In response to recent shutdowns of plants that use a gas called ethylene oxide to sterilize medical devices, FDA is challenging the industry to develop new approaches to device sterilization and to find ways to reduce emissions from the ethylene oxide sterilization process.

Amanda Pedersen | Jul 15, 2019

Click the play button below the following image for a quick overview of FDA's sterilization innovation challenges.

For more information on FDA's sterilization challenges, mark your calendar for the agency's upcoming webinar scheduled for August 13. In the meantime, click the following links to learn more about FDA Challenge 1 or FDA Challenge 2.

Hide comments

Load More

Comments

Plain text